Bayliss J
Br Med J (Clin Res Ed). 1981 Nov 7;283(6301):1207-9. doi: 10.1136/bmj.283.6301.1207.
A young woman had severe brittle diabetes mellitus that was critically unmanageable with all conventional insulin treatment. Continuous subcutaneous and intramuscular infusions of insulin also failed to control her metabolic instability. Use of a continuous intravenous infusion, however, whereby a portable, variable-rate, battery-operated syringe pump delivered insulin through a subcutaneously tunnelled central venous catheter, resulted in good control. When she was receiving hourly intramuscular insulin injections (a mean of 778 IU daily) mean blood glucose concentrations had been 22.1 +/- 1.4 mmol/l (398 +/- 25 mg/100 microliters). After she had received the intravenous infusion for one month as an outpatient mean blood glucose concentration was 8.2 +/- 0.46 mmol/l (148 +/- 8 mg/100 microliters) and only 80 IU insulin daily was required. Follow-up after over five months of use showed that few complications had occurred. The system is simple to use and safe, and the diabetes had been stabilised such that she could enjoy a near-normal life style.
一名年轻女性患有严重的脆性糖尿病,所有传统胰岛素治疗都难以有效控制病情。持续皮下和肌肉注射胰岛素也无法控制她的代谢不稳定状况。然而,使用持续静脉输注法,即通过皮下隧道式中心静脉导管,由便携式、可变速率、电池驱动的注射器泵输送胰岛素,实现了良好的控制效果。在她接受每小时一次的肌肉注射胰岛素时(平均每日778国际单位),平均血糖浓度为22.1±1.4毫摩尔/升(398±25毫克/100微升)。作为门诊患者接受静脉输注一个月后,平均血糖浓度为8.2±0.46毫摩尔/升(148±8毫克/100微升),且每日仅需80国际单位胰岛素。使用超过五个月后的随访显示,几乎没有发生并发症。该系统使用简单且安全,糖尿病病情已得到稳定,她能够过上近乎正常的生活方式。